• 10/4/24: Recapping the NIH RECOVER-TLC kickoff

  • 2024/10/04
  • 再生時間： 24 分
  • ポッドキャスト

10/4/24: Recapping the NIH RECOVER-TLC kickoff

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In the pilot episode of Still Here: A Podcast From The Sick Times, co-hosts Miles Griffis and Betsy Ladyzhets talk with podcast producer James Salanga about the latest COVID-19 numbers. Engagement editor Heather Hogan joins James, Miles, and Betsy to recap the NIH RECOVER-TLC meeting from last week. And in research, a hopeful update about a nasal spray effective at blocking respiratory viruses — including COVID-19. The transcript for this podcast is available on our website. You can jump to specific sections of the transcript and podcast below. (00:00:00) Intro (00:02:15) COVID-19 trends (00:04:55) Top story — Recap of NIH RECOVER-TLC meeting and reflections (00:22:15) Research — A nasal spray that performed well in preclinical trials (00:23:00) Outro and credits You can also find our podcast on Apple Podcasts, Pocket Casts, Amazon Music and iHeartRadio. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, October 1CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardThe Sick Times: ‘They bungled it:’ NIH documents reveal how $1.6 billion Long Covid initiative has failed so far to meet its goalsThe Sick Times: Q&A: NIH Director Dr. Monica Bertagnolli on next steps for RECOVER, future Long COVID research plans, and more The Sick Times: Live blog: Following the RECOVER-Treating Long COVID kickoff eventThe Sick Times: “A good step”: Long COVID advocates and researchers respond to the RECOVER-Treating Long COVID meeting National Academies Press: Global Functioning in Long COVIDJAMA Network: Characterizing Long COVID in Children and AdolescentsThe Sick Times: Five reasons why the NIH should retract the “effort preference” claims in their intramural ME/CFS paperNIH RECOVER websiteRECOVER-TLC: Submit a therapeutic to be considered in a clinical trialHarvard Gazette: Drug-free nasal spray blocks, neutralizes viruses, bacteria Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示

あらすじ・解説

In the pilot episode of Still Here: A Podcast From The Sick Times, co-hosts Miles Griffis and Betsy Ladyzhets talk with podcast producer James Salanga about the latest COVID-19 numbers. Engagement editor Heather Hogan joins James, Miles, and Betsy to recap the NIH RECOVER-TLC meeting from last week. And in research, a hopeful update about a nasal spray effective at blocking respiratory viruses — including COVID-19. The transcript for this podcast is available on our website. You can jump to specific sections of the transcript and podcast below. (00:00:00) Intro (00:02:15) COVID-19 trends (00:04:55) Top story — Recap of NIH RECOVER-TLC meeting and reflections (00:22:15) Research — A nasal spray that performed well in preclinical trials (00:23:00) Outro and credits You can also find our podcast on Apple Podcasts, Pocket Casts, Amazon Music and iHeartRadio. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, October 1CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardThe Sick Times: ‘They bungled it:’ NIH documents reveal how $1.6 billion Long Covid initiative has failed so far to meet its goalsThe Sick Times: Q&A: NIH Director Dr. Monica Bertagnolli on next steps for RECOVER, future Long COVID research plans, and more The Sick Times: Live blog: Following the RECOVER-Treating Long COVID kickoff eventThe Sick Times: “A good step”: Long COVID advocates and researchers respond to the RECOVER-Treating Long COVID meeting National Academies Press: Global Functioning in Long COVIDJAMA Network: Characterizing Long COVID in Children and AdolescentsThe Sick Times: Five reasons why the NIH should retract the “effort preference” claims in their intramural ME/CFS paperNIH RECOVER websiteRECOVER-TLC: Submit a therapeutic to be considered in a clinical trialHarvard Gazette: Drug-free nasal spray blocks, neutralizes viruses, bacteria Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall
政治・政府
続きを読む 一部表示

10/4/24: Recapping the NIH RECOVER-TLC kickoffに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。